Regulatory News:

At 31 December 2024, resources made available for the liquidity agreement concluded by Carmila (Paris:CARM) with Kepler Chevreux were the following:

- 45,945 CARMILA shares; - Euro 1,032,564.

During the 2nd half-year 2024, it has been negotiated a total of:

- For purchase, 463,075 shares, for a total amount of Euro 7,881,373 (1,702 transactions); - For sale, 497,615 shares, for a total amount of Euro 8,429,556 (1,787 transactions).

For information, at the time of the last assessments, available resources were:

1. At the time of the previous half-yearly assessment at June 30, 2024, available resources were:

- 80,485 CARMILA shares; - Euro 472,898.

2. During the 1st half-year 2024, it has been negotiated a total of:

- For purchase, 393,209 shares, for a total amount of Euro 6,354,864 (2,110 transactions); - For sale, 367,163 shares, for a total amount of Euro 5,921,661 (1,661 transactions).

3. As of July 1st, 2021, date of implementation of the AMF decision n°2021-01 dated June 22, 2021, the following resources were:

- 112,910 CARMILA shares ; - Euro 991,074.

4. As of December 31, 2018, date of implementation of the AMF decision n°2018-1 dated July 2, 2018, the following resources were:

- 203,848 CARMILA shares; - Euro 743,970.

*withdrawal of 102,358 shares on July 1st, 2019.

INVESTOR AGENDA

February 11, 2025 (after market close): Publication of 2024 full-year results February 12, 2025 (09:00 am CET): Presentation of 2024 full-year results

ABOUT CARMILA

As the third-largest listed owner of commercial property in Europe, Carmila was founded by Carrefour and large institutional investors in order to enhance the value of shopping centres adjoining Carrefour hypermarkets in France, Spain and Italy. At June 30, 2024, its portfolio was valued at €5.9 billion and is made up of 201 shopping centres, with leading positions in their catchment areas.

Carmila is listed on Euronext-Paris Compartment A under the symbol CARM. It benefits from the tax regime for French real estate investment trusts (“SIIC”).

Carmila has been a member of the SBF 120 since June 20, 2022.

IMPORTANT NOTICE

Some of the statements contained in this document are not historical facts but rather statements of future expectations, estimates and other forward-looking statements based on management’s beliefs. These statements reflect such views and assumptions prevailing as of the date of the statements and involve known and unknown risks and uncertainties that could cause future results, performance or events to differ materially from those expressed or implied in such statements. Please refer to the most recent Universal Registration Document filed in French by Carmila with the Autorité des marchés financiers for additional information in relation to such factors, risks and uncertainties. Carmila has no intention and is under no obligation to update or review the forward-looking statements referred to above. Consequently, Carmila accepts no liability for any consequences arising from the use of any of the above statements.

This press release is available in the “Regulated Information” section of Carmila’s Finance webpage: https://www.carmila.com/en/finance/regulated-information/

Visit our website at www.carmila.com/en/

INVESTOR AND ANALYST CONTACT Pierre-Yves Thirion - CFO pierre_yves_thirion@carmila.com +33 6 47 21 60 49

PRESS CONTACT Elodie Arcayna – Corporate Communications Director elodie_arcayna@carmila.com +33 7 86 54 40 10

Carisma Therapeutics (NASDAQ:CARM)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025 Haga Click aquí para más Gráficas Carisma Therapeutics.
Carisma Therapeutics (NASDAQ:CARM)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025 Haga Click aquí para más Gráficas Carisma Therapeutics.